These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 32597263)

  • 1. Therapeutic drug monitoring of β-lactam antibiotics in the ICU.
    Dhaese S; Van Vooren S; Boelens J; De Waele J
    Expert Rev Anti Infect Ther; 2020 Nov; 18(11):1155-1164. PubMed ID: 32597263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards precision medicine: Therapeutic drug monitoring-guided dosing of vancomycin and β-lactam antibiotics to maximize effectiveness and minimize toxicity.
    Cusumano JA; Klinker KP; Huttner A; Luther MK; Roberts JA; LaPlante KL
    Am J Health Syst Pharm; 2020 Jul; 77(14):1104-1112. PubMed ID: 32537644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic aspects of beta-lactam antibiotic therapy in intensive care unit patients: A one-center experience with TDM.
    Sadilová K; Halačová M; Černý D
    Ceska Slov Farm; 2020; 69(1):17-23. PubMed ID: 32460506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of β-lactam antibiotic therapeutic drug monitoring on dose adjustments in critically ill patients undergoing continuous renal replacement therapy.
    Economou CJP; Wong G; McWhinney B; Ungerer JPJ; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2017 May; 49(5):589-594. PubMed ID: 28341612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of therapeutic drug monitoring of beta-lactam and fluoroquinolones on clinical outcome in critically ill patients: the DOLPHIN trial protocol of a multi-centre randomised controlled trial.
    Abdulla A; Ewoldt TMJ; Hunfeld NGM; Muller AE; Rietdijk WJR; Polinder S; van Gelder T; Endeman H; Koch BCP
    BMC Infect Dis; 2020 Jan; 20(1):57. PubMed ID: 31952493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study protocol for ADAPT-TDM: A beta-lactam antibiotic Dose AdaPtation feasibility randomised controlled Trial using Therapeutic Drug Monitoring.
    Pai Mangalore R; Chai MG; Pope J; Lee SJ; Padiglione A; Diehl A; Roberts L; Sim K; Rawson-Harris P; Wicha S; Schneider HG; Peel TN; Jenney A; Ayton D; Peleg AY; Udy AA
    BMJ Open; 2024 Jul; 14(6):e083635. PubMed ID: 38951004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose optimization of β-lactam antibiotics in children: from population pharmacokinetics to individualized therapy.
    Ngougni Pokem P; Vanneste D; Schouwenburg S; Abdulla A; Gijsen M; Dhont E; Van der Linden D; Spriet I; De Cock P; Koch B; Van Bambeke F; Wijnant GJ
    Expert Opin Drug Metab Toxicol; 2024 Aug; 20(8):787-804. PubMed ID: 39078238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics/Pharmacodynamics of β-Lactams and Therapeutic Drug Monitoring: From Theory to Practical Issues in the Intensive Care Unit.
    Williams P; Cotta MO; Roberts JA
    Semin Respir Crit Care Med; 2019 Aug; 40(4):476-487. PubMed ID: 31585474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.
    Wong G; Brinkman A; Benefield RJ; Carlier M; De Waele JJ; El Helali N; Frey O; Harbarth S; Huttner A; McWhinney B; Misset B; Pea F; Preisenberger J; Roberts MS; Robertson TA; Roehr A; Sime FB; Taccone FS; Ungerer JP; Lipman J; Roberts JA
    J Antimicrob Chemother; 2014 May; 69(5):1416-23. PubMed ID: 24443514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of the practical impact of adjusting beta-lactam dosages based on therapeutic drug monitoring in critically ill adult patients: a systematic review and meta-analysis of randomized clinical trials and observational studies.
    Gulyás E; Horváth IL; Engh MA; Bunduc S; Dembrovszky F; Fehérvári P; Bánvölgyi A; Csupor D; Hegyi P; Karvaly GB
    Sci Rep; 2024 Apr; 14(1):7793. PubMed ID: 38565898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic Stewardship and Therapeutic Drug Monitoring of β-Lactam Antibiotics: Is There a Link? An Opinion Paper.
    Richter DC; Heininger A; Chiriac U; Frey OR; Rau H; Fuchs T; Röhr AC; Brinkmann A; Weigand MA
    Ther Drug Monit; 2022 Feb; 44(1):103-111. PubMed ID: 34857694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A narrative review of predictors for β-lactam antibiotic exposure during empirical treatment in critically ill patients.
    Abdulla A; Ewoldt TMJ; Purmer IM; Muller AE; Gommers D; Endeman H; Koch BCP
    Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):359-368. PubMed ID: 33463382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Drug Monitoring of Beta-Lactams and Other Antibiotics in the Intensive Care Unit: Which Agents, Which Patients and Which Infections?
    Muller AE; Huttner B; Huttner A
    Drugs; 2018 Mar; 78(4):439-451. PubMed ID: 29476349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia.
    Hayashi Y; Lipman J; Udy AA; Ng M; McWhinney B; Ungerer J; Lust K; Roberts JA
    Int J Antimicrob Agents; 2013 Feb; 41(2):162-6. PubMed ID: 23153962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the DMAIC Lean Six Sigma quality improvement framework to improve beta-lactam antibiotic adequacy in the critically ill.
    Wessel RJ; Rivera CG; Ausman SE; Martin N; Braga SA; Hagy NT; Moreland-Head LN; Abu Saleh OM; Gajic O; Jannetto PJ; Barreto EF
    Int J Qual Health Care; 2024 Jul; 36(3):. PubMed ID: 38955670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics-pharmacodynamics issues relevant for the clinical use of beta-lactam antibiotics in critically ill patients.
    Veiga RP; Paiva JA
    Crit Care; 2018 Sep; 22(1):233. PubMed ID: 30244674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper
    Abdul-Aziz MH; Alffenaar JC; Bassetti M; Bracht H; Dimopoulos G; Marriott D; Neely MN; Paiva JA; Pea F; Sjovall F; Timsit JF; Udy AA; Wicha SG; Zeitlinger M; De Waele JJ; Roberts JA; ; ; ;
    Intensive Care Med; 2020 Jun; 46(6):1127-1153. PubMed ID: 32383061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ANTIBIOPERF study: a nationwide cross-sectional survey about practices for β-lactam administration and therapeutic drug monitoring among critically ill patients in France.
    Charmillon A; Novy E; Agrinier N; Leone M; Kimmoun A; Levy B; Demoré B; Dellamonica J; Pulcini C
    Clin Microbiol Infect; 2016 Jul; 22(7):625-31. PubMed ID: 27145210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic monitoring of antibiotics: New methodologies: biosensors].
    Soto D; Silva C; Andresen V M; Soto N; Wong KY; Andresen M
    Rev Med Chil; 2015 Aug; 143(8):1050-7. PubMed ID: 26436935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical application of beta-lactam antibiotic therapeutic drug monitoring in the critical care setting.
    Pai Mangalore R; Peel TN; Udy AA; Peleg AY
    J Antimicrob Chemother; 2023 Oct; 78(10):2395-2405. PubMed ID: 37466209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.